Literature DB >> 30607108

Conflict of interest: "Be rigorous in judging ourselves and gracious in judging others".

B Basulaiman1, A Awan1, J F Hilton1,2, M Clemons1,2.   

Abstract

Mesh：

Year:  2018        PMID： 30607108      PMCID： PMC6291281          DOI： 10.3747/co.25.4587

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  12 in total

1.  All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

Authors:  Dana Katz; Arthur L Caplan; Jon F Merz
Journal:  Am J Bioeth       Date:  2003       Impact factor: 11.229

2.  The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

Authors:  J P Orlowski; L Wateska
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

3.  Questioning Our APHINITY for More.

Authors:  Kathy D Miller
Journal:  N Engl J Med       Date:  2017-06-05       Impact factor: 91.245

4.  Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.

Authors:  N Lurie; E C Rich; D E Simpson; J Meyer; D L Schiedermayer; J L Goodman; W P McKinney
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

5.  Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.

Authors:  Colette DeJong; Thomas Aguilar; Chien-Wen Tseng; Grace A Lin; W John Boscardin; R Adams Dudley
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

6.  Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Authors:  Gunter von Minckwitz; Marion Procter; Evandro de Azambuja; Dimitrios Zardavas; Mark Benyunes; Giuseppe Viale; Thomas Suter; Amal Arahmani; Nathalie Rouchet; Emma Clark; Adam Knott; Istvan Lang; Christelle Levy; Denise A Yardley; Jose Bines; Richard D Gelber; Martine Piccart; Jose Baselga
Journal:  N Engl J Med       Date:  2017-06-05       Impact factor: 91.245

7.  Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.

Authors:  José Baselga; Karen A Gelmon; Shailendra Verma; Andrew Wardley; Pierfranco Conte; David Miles; Giulia Bianchi; Javier Cortes; Virginia A McNally; Graham A Ross; Pierre Fumoleau; Luca Gianni
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

8.  The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

Authors:  Art Van Zee
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

9.  Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.

Authors:  Carmel Jacobs; Ian D Graham; Julie Makarski; Michaël Chassé; Dean Fergusson; Brian Hutton; Mark Clemons
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

10.  Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study.

Authors:  Andrew Grey; Alison Avenell; Nicola Dalbeth; Fiona Stewart; Mark J Bolland
Journal:  BMJ Open       Date:  2017-09-21       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.